Skip to main content

Client News

Newron TRS study 6 months’ results: Evenamide substantially improves patients to an extent that they no longer meet protocol entry criteria

9th October 2023

Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit

5th October 2023

Rentschler Biopharma and Friedrich-Adler-Realschule Laupheim sign cooperation agreement to enhance school education with additional practical experience

5th October 2023

Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania

4th October 2023

Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress

4th October 2023

Carbios unveils major innovation in polyester recycling with new textile preparation line, in the presence of Roland Lescure, French Minister of Industry

2nd October 2023

Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023

2nd October 2023

Newron appoints Margarita Chavez as board advisor

2nd October 2023

Abivax files registration statement for proposed initial public offering in the United States

29th September 2023

Abivax announces the release of its 2023 half-year financial report

29th September 2023